avail
literatur
concern
util
manag
clinic
microbiolog
laboratori
rel
limit
compar
highvolum
autom
test
central
core
laboratori
howev
strategi
employ
elsewher
clinic
laboratori
oper
appli
util
manag
challeng
microbiolog
includ
decis
support
system
applic
evidencebas
medicin
screen
algorithm
gatekeep
function
result
test
microbiolog
laboratori
signific
effect
cost
clinic
care
especi
cost
relat
antimicrobi
agent
infect
control
practic
consequ
mani
success
util
manag
intervent
describ
clinic
microbiolog
target
volum
test
perform
laboratori
also
downstream
cost
care
articl
review
util
manag
strategi
clinic
microbiolog
includ
specif
exampl
institut
healthcar
organ
clinic
microbiolog
includ
bacteriolog
antimicrobi
suscept
test
virolog
parasitolog
mycobacteriolog
mycolog
serolog
molecular
microbiolog
unlik
core
laboratori
chemistryhematolog
major
test
perform
highli
autom
analyz
test
microbiolog
perform
manual
semiautom
platform
mani
microbiolog
test
also
requir
interpret
skill
microbiolog
technologist
includ
visual
interpret
cultur
result
microscop
examin
reason
unit
cost
microbiolog
test
usual
greater
routin
autom
test
result
microbiolog
test
signific
impact
overal
cost
clinic
care
notabl
use
select
antimicrobi
therapi
therefor
approach
util
manag
microbiolog
import
consid
cost
test
within
microbiolog
laboratori
also
downstream
cost
result
clinic
decis
base
test
result
publish
literatur
util
manag
microbiolog
rel
limit
compar
report
manag
util
routin
autom
test
chemistri
hematolog
laboratori
articl
outlin
number
util
manag
intervent
microbiolog
report
literatur
also
describ
sever
unpublish
initi
proven
success
institut
specif
intervent
discuss
outlin
tabl
describ
detail
text
follow
number
case
initi
success
aros
reduct
laboratori
test
per
se
rather
also
impact
clinic
care
arena
exampl
reduct
antibiot
use
hospit
length
lengthofstay
observ
highlight
import
clinic
microbiolog
director
form
collabor
interdepartment
team
improv
qualiti
reduc
cost
medic
care
test
cytomegaloviru
cmv
includ
antigenemia
test
viral
load
test
quantit
polymeras
chain
reaction
qpcr
viral
genotyp
shell
vial
cultur
serolog
test
detect
host
immunolog
respons
cmv
igm
igg
antibodi
test
antibodi
avid
test
individu
patient
appropri
test
depend
clinic
indic
difficult
clinician
keep
uptod
esoter
test
rapidli
evolv
specialti
especi
numer
test
order
situat
use
decis
support
tool
effect
mechan
assist
physician
proper
test
select
potenti
avoid
inappropri
test
select
one
exampl
fig
show
screen
display
onlin
laboratori
handbook
massachusett
gener
hospit
clinician
type
cytomegaloviru
cmv
handbook
search
function
avail
test
appropri
indic
present
addit
decisionsupport
inform
provid
electron
physician
order
entri
poe
system
clinician
view
cmvrelat
test
option
advantag
featur
approach
new
test
becom
avail
outdat
one
remov
test
menu
decisionsupport
function
updat
accordingli
exampl
mgh
microbiolog
laboratori
recent
discontinu
cmv
antigenemia
assay
favor
cmv
qpcr
test
inform
provid
onlin
handbook
make
clear
prefer
test
chang
approach
appli
mani
test
microbiolog
particularli
area
molecular
microbiolog
new
assay
supplant
tradit
assay
rapid
rate
topic
decis
support
cover
detail
anoth
chapter
special
edit
problem
contamin
blood
cultur
improp
poor
techniqu
well
known
estim
posit
blood
cultur
may
repres
contamin
result
signific
increas
resourc
util
consequ
mani
hospit
engag
ongo
effort
reduc
blood
cultur
contamin
improv
staff
train
design
specif
type
employe
collect
blood
cultur
specimen
exampl
blood
cultur
collect
medic
hous
offic
like
contamin
collect
phlebotomist
retrospect
studi
bate
et
al
studi
impact
contamin
blood
cultur
hospit
lengthofstay
hospit
charg
patient
fals
posit
blood
cultur
increas
median
lengthofstay
increas
hospit
charg
falseposit
episod
associ
increas
pharmaci
charg
intraven
antibiot
increas
laboratori
charg
increas
anoth
studi
segal
chamberlain
assess
impact
falseposit
blood
cultur
pediatr
emerg
depart
author
report
increas
phone
call
return
visit
emerg
depart
unnecessari
laboratori
test
inappropri
antibiot
administr
hospit
admiss
final
tabriz
et
al
evalu
practic
repeat
blood
cultur
serial
blood
cultur
repeat
case
amount
approxim
onethird
blood
cultur
handl
laboratori
result
repeat
cultur
show
growth
case
pathogen
case
new
pathogen
contamin
case
respect
author
conclud
repeat
blood
cultur
provid
littl
addit
yield
guidelin
repeat
blood
cultur
might
decreas
util
laboratori
report
optim
design
lead
confus
among
clinician
potenti
misdiagnosi
unnecessari
request
addit
test
ackerman
et
al
evalu
interpret
typic
microbiolog
report
physician
teach
hospit
investig
found
report
often
misinterpret
exampl
one
report
isol
gram
neg
rod
sputum
misinterpret
physician
reason
misinterpret
report
use
jargon
unfamiliar
name
bacteri
speci
illdefin
report
convent
omiss
clearcut
conclus
mani
report
misunderstand
result
inappropri
use
antibiot
order
unnecessari
test
laboratori
studi
highlight
import
develop
clear
concis
standard
report
format
microbiolog
need
laboratori
work
close
physician
design
commun
microbiolog
report
rapid
identif
bacteria
use
matrixassist
laser
desorptionion
time
flight
mass
spectroscopi
malditof
ms
improv
clinic
decis
make
guid
antibiot
use
long
known
rapid
bacteri
identif
suscept
test
lead
appropri
use
antibiot
reduct
antimicrobi
util
past
rapid
identif
suscept
test
mainli
accomplish
use
autom
instrument
perform
convent
test
recent
manufactur
develop
malditof
ms
rapid
organ
identif
method
demonstr
reduc
turnaround
time
identif
bacteria
yeast
day
compar
convent
method
anoth
advantag
malditof
ms
simplic
rel
low
cost
consum
tabl
exampl
util
manag
initi
clinic
microbiolog
see
text
detail
decis
support
test
select
cytomegaloviru
test
reduc
blood
cultur
contamin
proper
format
microbiolog
report
avoid
misinterpret
use
malditof
mass
spectroscopi
rapid
identif
pathogen
antimicrobi
stewardship
carbapenem
expens
antimicrobi
agent
rapid
pointofcar
test
influenza
group
streptococcu
impact
test
order
antibiot
util
rapid
molecular
diagnost
test
patient
previous
colon
methicillin
resist
staphylococcu
aureu
mrsa
use
screen
method
reduc
lowyield
urin
cultur
restrict
stool
examin
hospit
acquir
diarrhea
rapid
test
respiratori
virus
impact
inpati
bed
manag
applic
evid
base
medicin
discontinu
fungal
blood
cultur
select
oversight
molecular
diagnost
microbiolog
exampl
one
studi
perform
larg
academ
medic
center
demonstr
potenti
cost
save
laboratori
reagent
labor
per
year
although
malditof
ms
provid
antimicrobi
suscept
data
rapid
organ
identif
may
help
clinician
earlier
select
effect
empir
antimicrobi
strategi
carbapenem
includ
imipenem
meropenem
ertapenem
doripenem
broad
spectrum
antimicrobi
agent
activ
mani
gramposit
gramneg
anaerob
organ
highli
effect
use
appropri
also
expens
rel
potenti
altern
agent
indiscrimin
use
carbapenem
also
contribut
antimicrobi
resist
decreas
effect
drug
class
mani
hospit
establish
antimicrobi
formulari
pharmaci
assist
manag
expens
antibiot
drug
institut
antibiot
restrict
obtain
approv
divis
infecti
diseas
howev
approv
requir
formal
mechan
place
reevalu
ongo
need
restrict
antibiot
result
microbiolog
cultur
antimicrobi
suscept
test
becam
avail
clinic
patholog
staff
microbiolog
laboratori
recent
began
antimicrobi
stewardship
program
relat
carbapenem
day
microbiolog
fellow
laboratori
director
review
clinic
histori
cultur
result
suscept
test
result
patient
newli
start
carbapenem
determin
appropri
versu
inappropri
use
drug
object
data
indic
patient
infect
treat
use
nonrestrict
agent
email
sent
clinician
shown
exampl
dear
dr
patient
current
receiv
restrict
antibiot
ertapenem
use
restrict
drug
monitor
mgh
antimicrobi
stewardship
program
recent
cultur
antimicrobi
suscept
data
patient
reveal
organ
isar
suscept
nonrestrict
antibiot
see
sensit
report
given
data
clinic
appropri
pleas
consid
discontinu
restrict
carbapenem
andor
chang
nonrestrict
antimicrobi
option
may
help
reduc
develop
futur
resist
broad
spectrum
drug
cost
therapi
alreadi
done
may
request
infecti
diseas
consult
order
obtain
assist
choic
antimicrobi
agent
implement
stewardship
effort
decreas
carbapenem
use
observ
carbapenem
remov
top
list
money
spent
antimicrobi
microbiolog
group
extend
program
includ
high
cost
antimicrobi
pointofcar
test
poct
perform
patient
bedsid
provid
rapid
realtim
result
case
facilit
clinic
decis
make
improv
effici
clinic
oper
number
rapid
pointofcar
test
avail
diagnosi
infecti
diseas
among
singl
use
visual
read
later
flow
test
influenza
b
random
prospect
control
studi
bonner
et
al
use
rapid
poc
influenza
test
pediatr
emerg
depart
associ
signific
reduct
laboratori
test
order
complet
blood
count
blood
cultur
urinalysi
urin
cultur
decreas
chest
radiograph
perform
reduct
emerg
depart
lengthofstay
anoth
studi
pediatr
patient
present
emerg
depart
acut
pharyng
author
compar
antibiot
use
patient
receiv
rapid
streptococcu
test
manag
convent
throat
cultur
alon
report
decreas
antibiot
use
rapid
test
employ
versu
conclud
rapid
test
significantli
reduc
unnecessari
prescript
antibiot
patient
colon
mrsa
requir
contact
precaut
admit
hospit
entail
place
privat
room
cohort
patient
semipriv
room
anoth
colon
patient
addit
hospit
staff
must
wear
glove
gown
use
dedic
equip
interact
patient
patient
also
longer
hospit
length
stay
due
delay
discharg
health
care
facil
collect
featur
mrsa
colon
result
greater
use
hospit
resourc
compar
nonmrsa
colon
patient
mrsa
colon
transient
protocol
put
place
identifi
previous
mrsa
colon
patient
longer
colon
manag
without
contact
precaut
institut
patient
histori
mrsa
elig
discontinu
contact
precaut
either
screen
method
patient
receiv
antibiot
activ
mrsa
h
prior
screen
discontinu
contact
precaut
basi
singl
neg
mrsa
pcr
faster
screen
use
culturebas
method
could
result
increas
discontinu
contact
precaut
reduct
number
sampl
need
uncompl
urinari
tract
infect
common
especi
among
women
variou
strategi
employ
make
rule
diagnosi
commun
acquir
uti
adult
women
without
need
urin
cultur
sourc
suggest
uncompl
uti
outpati
diagnos
manag
without
cultur
unless
patient
fail
treatment
recurr
uti
other
even
suggest
suspect
uti
manag
telephon
women
typic
symptom
cystiti
without
vagin
symptom
major
comorbid
approach
elimin
offic
visit
subsequ
laboratori
test
anoth
approach
limit
urin
cultur
util
prescreen
urin
use
variou
method
exampl
dipstick
urinalysi
leukocyt
esteras
nitrit
high
neg
predict
valu
may
use
exclud
bacteriuria
without
cultur
step
result
neg
studi
also
demonstr
urin
screen
signific
bacteriuria
prior
cultur
use
autom
urin
sediment
examin
flow
cytometri
diarrhea
common
complaint
among
hospit
patient
although
common
clinician
request
routin
stool
cultur
ova
parasit
p
examin
patient
diarrhea
test
design
detect
agent
communityacquir
rather
hospitalacquir
infect
number
studi
indic
routin
stool
cultur
stool
p
examin
usual
warrant
adult
patient
develop
diarrhea
three
day
admiss
hospit
contrast
test
clostridium
difficil
consid
major
caus
nosocomi
diarrheal
ill
new
molecular
diagnost
test
offer
promis
provid
rapid
reliabl
test
c
difficil
highli
sensit
molecular
test
could
potenti
permit
rapid
ruleout
c
difficil
obviat
need
unnecessari
antibiot
contact
precaut
mani
patient
upper
respiratori
viral
infect
unit
state
frequent
caus
rhinovirus
coronavirus
influenza
b
parainfluenza
respiratori
syncyti
viru
adenoviru
metapneumoviru
mani
ill
manag
outpati
basi
patient
sever
ill
major
comorbid
often
admit
hospit
usual
present
first
emerg
depart
initi
challeng
confirm
presenc
respiratori
viral
infect
identifi
specif
offend
viru
order
direct
specif
therapi
avail
aid
hospit
bed
assign
often
respiratori
viral
infect
occur
season
epidem
especi
influenza
b
result
hospit
overcrowd
shortag
hospit
bed
occur
manag
avail
hospit
bed
becom
prioriti
case
offend
viru
identifi
contact
andor
droplet
precaut
must
institut
prevent
transmiss
patient
shown
tabl
patient
contact
droplet
precaut
must
place
privat
room
altern
two
patient
infect
respiratori
viru
cohort
togeth
one
hospit
room
hospit
offer
rapid
molecular
diagnost
test
influenza
b
patient
requir
hospit
admiss
flulik
ill
test
perform
h
per
day
day
per
week
order
facilit
bed
manag
time
initi
antivir
therapi
also
offer
respiratori
viral
panel
direct
immunofluoresc
mani
virus
list
day
per
week
peak
respiratori
viru
season
abil
identifi
specif
viru
caus
infect
greatli
assist
manag
inpati
bed
maintain
effect
infect
control
measur
save
hospit
improv
bed
manag
epidem
greatli
exce
cost
test
laboratori
mani
clinic
laboratori
offer
fungal
blood
cultur
employ
special
media
design
enhanc
detect
yeast
mold
fungemia
howev
wellestablish
special
fungal
blood
cultur
media
superior
routin
blood
cultur
media
detect
candida
fungemia
candidemia
thu
main
rational
use
fungal
blood
cultur
improv
detect
cryptococc
yeast
endem
fungi
histoplasma
capsulatum
coccidioid
spp
etc
filament
fungi
eg
aspergillu
spp
blood
recent
institut
offer
fungal
blood
cultur
use
myco
f
lytic
bottl
becton
dickinson
design
use
bactec
autom
cultur
monitor
system
approach
costli
term
reagent
cost
also
term
technic
labor
highlyenrich
nonselect
cultur
medium
need
incub
day
neg
result
could
obtain
frequent
promot
growth
eventu
detect
skin
contamin
would
detect
use
routin
blood
cultur
bottl
day
incub
period
thu
review
experi
approach
understand
whether
provid
signific
clinic
benefit
review
result
fungal
blood
cultur
month
period
time
period
mycof
lytic
fungal
blood
cultur
perform
review
reveal
follow
dimorph
fungi
recov
fungal
blood
cultur
mold
fusarium
sp
recov
twice
singl
patient
use
fungal
blood
cultur
howev
case
fusarium
also
recov
set
routin
blood
cultur
bottl
sever
day
prior
recoveri
fungal
blood
cultur
cryptococcu
neoforman
recov
patient
fungal
blood
cultur
two
patient
cryptococc
mening
case
organ
detect
numer
way
csf
blood
cryptococc
antigen
test
csf
gram
stain
routin
fungal
csf
cultur
routin
blood
cultur
third
patient
cryptococc
fungemia
mening
cryptococc
antigen
test
blood
posit
organ
recov
twice
routin
blood
cultur
base
find
conclud
fungal
blood
cultur
fail
detect
dimorph
fungi
mold
cryptococc
yeast
otherwis
detect
routin
blood
cultur
furthermor
blood
cultur
use
method
detect
invas
infect
caus
mold
dimorph
fungi
therefor
blood
cultur
specif
design
detect
fungi
discontinu
institut
mani
microbiolog
test
suffer
drawback
limit
clinic
util
exampl
result
tradit
cultur
method
may
take
sever
day
becom
avail
antibiot
treatment
prior
specimen
collect
may
degrad
sensit
serolog
studi
often
distinguish
current
past
infect
unless
acut
convalesc
specimen
avail
techniqu
special
cultur
virus
beyond
capabl
hospit
laboratori
final
mani
microbiolog
test
yield
quantit
result
may
desir
situat
recent
advanc
molecular
diagnost
techniqu
microbiolog
offer
promis
resolv
issu
molecular
test
influenza
b
hepat
b
viru
dna
hiv
viral
load
request
suffici
volum
mani
hospit
laboratori
abl
offer
test
inhous
exampl
molecular
diagnost
test
either
superior
altern
test
method
provid
uniqu
inform
clinic
import
eg
viral
load
howev
mani
case
volum
request
molecular
microbiolog
test
low
warrant
perform
test
hospit
laboratori
typic
test
sent
outsid
refer
laboratori
analysi
time
prove
expens
intuit
molecular
diagnost
test
expect
highli
sensit
specif
alway
case
situat
convent
microbiolog
test
appropri
reason
import
clinic
microbiolog
director
work
infecti
diseas
specialist
scrutin
send
budget
potenti
inappropri
test
order
analysi
may
reveal
opportun
insourc
test
signific
save
exampl
microbiolog
laboratori
recent
insourc
nucleicacid
test
epstein
bar
viru
ebv
save
per
year
provid
superior
turnaround
time
test
perform
clinic
microbiolog
laboratori
ripe
util
manag
effort
clinician
frequent
confus
test
order
appropri
test
select
guid
decis
support
mechan
gatekeep
function
diagnost
yield
routin
cultur
improv
facilit
proper
specimen
collect
transport
screen
specimen
prior
cultur
clinic
decis
make
particularli
select
appropri
antibiot
implement
discontinu
infect
control
measur
aid
effort
reduc
turnaround
time
antimicrobi
stewardship
effort
direct
microbiologist
final
error
prevent
care
format
report
avoid
miscommun
